DFH explained in a press release that test results may indicate one of three primary outcomes:
- Active infection.
- Past infection and some level of immunity.
- No exposure and no immunity.
According to the release, DSL has developed three tests for COVID-19 and SARS-CoV-2: an oral and nasopharyngeal swab diagnostic test for COVID-19, and a stool analysis and blood serum test for SARS-CoV-2.
The blood serum test, which provides information about whether an individual’s immune system has responded in some way to an exposure to SARS-CoV-2, can be used for screening of both people with symptoms and people without symptoms, the company said, adding that this is important information in light of research suggesting that a high percentage of people who carry the virus show no clinical symptoms.
“We are living in unchartered times and whatever we can do to help people through this terrible crisis we will,” said Jonathan Lizotte, Founder and Chairman of DFH. “All the tests will be performed by Diagnostic Solutions Laboratory, and the results will be sent directly to each individual along with general information about the range of possible results. DFH will have no access to the employees’ individual results, which are their personal health information. We have instructed people whose antibody test shows they may be fighting an active infection to self-quarantine and contact their healthcare provider right away. If the results indicate a past infection and current immunity, they may be a good candidate to donate plasma. We will provide information about where employees can donate plasma in their local areas when this information becomes available. At the end of the day, the health of everyone in our company is a top priority for us.”